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Whole genome sequencing 
identifies bacterial factors affecting 
transmission of multidrug-resistant 
tuberculosis in a high-prevalence 
setting
Avika Dixit  1,2, Luca Freschi2, Roger Vargas2, Roger Calderon3, James Sacchettini4, 
Francis Drobniewski5, Jerome T. Galea6, Carmen Contreras3, Rosa Yataco3, Zibiao Zhang2,7, 
Leonid Lecca2,3, Sergios-Orestis Kolokotronis  8, Barun Mathema9 & Maha R. Farhat2,10
Whole genome sequencing (WGS) can elucidate Mycobacterium tuberculosis (Mtb) transmission 
patterns but more data is needed to guide its use in high-burden settings. In a household-based TB 
transmissibility study in Peru, we identified a large MIRU-VNTR Mtb cluster (148 isolates) with a range 
of resistance phenotypes, and studied host and bacterial factors contributing to its spread. WGS was 
performed on 61 of the 148 isolates. We compared transmission link inference using epidemiological or 
genomic data and estimated the dates of emergence of the cluster and antimicrobial drug resistance 
(DR) acquisition events by generating a time-calibrated phylogeny. Using a set of 12,032 public Mtb 
genomes, we determined bacterial factors characterizing this cluster and under positive selection in 
other Mtb lineages. Four of the 61 isolates were distantly related and the remaining 57 isolates diverged 
ca. 1968 (95%HPD: 1945–1985). Isoniazid resistance arose once and rifampin resistance emerged 
subsequently at least three times. Emergence of other DR types occurred as recently as within the last 
year of sampling. We identified five cluster-defining SNPs potentially contributing to transmissibility. In 
conclusion, clusters (as defined by MIRU-VNTR typing) may be circulating for decades in a high-burden 
setting. WGS allows for an enhanced understanding of transmission, drug resistance, and bacterial 
fitness factors.
Tuberculosis (TB) remains among the top ten causes of deaths globally, with 10.4 million new cases in 2016 
alone1. Peru remains a high burden country for multidrug-resistant (MDR) TB with 117 TB cases reported per 
100,000 population in 2016 and approximately 9% being MDR or rifampicin-resistant (RR)1. Molecular methods 
have been instrumental in identifying outbreaks, and single nucleotide polymorphism (SNPs) identified using 
whole genome sequencing (WGS) have a higher resolution in identifying transmission links compared to tradi-
tional genotyping methods such as spoligotyping or Mycobacterium interspersed repetitive unit-variable number 
tandem repeats (MIRU-VNTR)2–12. Yet we don’t yet fully understand how to use all the genetic information 
generated by WGS. By convention, as much as 10% of the genome is excluded2,3 and in some instances too little 
remaining variation is found to enable the resolution of transmission chains13. Resolving transmission events 
accurately is particularly challenging in high-burden settings where multiple source case suspects are common. 
In addition to guiding public health interventions including appropriate contact tracing, identifying the source 
case can inform patient care in some cases, such as in pediatric TB where the source case microbiological data can 
inform treatment14,15. Furthermore, in high-burden countries the term ‘outbreak’ may not apply as TB has been 
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circulating continuously for decades16. Given the renewed emphasis on active case finding17 and the widespread 
adoption of WGS, an intensification of the latter in high-burden settings is needed.
Control efforts against TB have been undermined by the emergence and spread of drug resistant TB (DR-TB). 
Current evidence suggests that most cases of DR-TB are a result of transmission rather than de-novo evolution 
of the bacteria during treatment18–20. Factors known to contribute to DR-TB transmission include delays in diag-
nosis and treatment21, host factors (e.g. age, immune status22–24), as well as bacterial factors such as fitness and 
immunogenicity characteristics25–27. It is well recognized that Mycobacterium tuberculosis (MTB) strains with the 
same DR-conferring mutations have a range of fitness28–30. However, to date few molecular fitness determinants 
have been characterized and seldom in the context of high transmissibility31–34. Improved knowledge of such 
bacterial factors can inform efforts for transmission interruption by identifying targets for diagnosis, surveillance, 
and even potential therapeutics targeting fitness mechanisms. Here we use WGS data to examine the largest 
TB MIRU-VNTR cluster spanning pan-susceptible to MDR-TB isolates that was identified in 4,000 TB patients 
enrolled in a household transmissibility study. We examine both host data and TB genotypic data to understand 
the evolution of isolates within this cluster, infer the timing of emergence of antibiotic resistance, and identify 
genetic bacterial factors unique to this cluster that may have contributed to its success.
Materials and Methods
Study Design. A TB household transmissibility and treatment outcome study was performed in northern 
Lima, Peru from September 2009 to August 2012. The study procedures including patient enrollment and consent 
have been previously described35,36. Briefly, informed consent was obtained from participants or their parents or 
guardians. Patients were enrolled if they were diagnosed with pulmonary TB (PTB) at public health clinics and 
were followed through therapy. Their household contacts were also followed with tuberculin skin testing and 
monitored for development of TB for a period of 12 months. The following were collected at time of TB diagnosis: 
clinical signs and symptoms, sociodemographic characteristics (e.g. age, gender, occupation, household type), 
geographical coordinates of household and health center, co-morbidities (HIV status, diabetes mellitus, renal 
disorder), as well as alcohol, tobacco and drug use.
Approval was obtained from the Research Ethics Committee of the Peruvian National Institute of Health 
(Lima, Peru) and the Committee on Human Studies at Harvard Medical School (Boston, MA). All research was 
performed in accordance with relevant guidelines and regulations.
Culture, DST and genotyping. Lowenstein-Jensen (LJ) culture was performed from sputum specimens 
using standard NALC-NaOH decontamination. All sputum cultures positive for MTB complex subspecies tuber-
culosis were subjected to first-line drug susceptibility testing (DST) for isoniazid (critical concentration of 1 µg/mL 
and 0.2 µg/mL), rifampicin (40 µg/mL), streptomycin (4 µg/mL) and ethambutol (2 µg/mL) using the proportion 
method. Pyrazinamide susceptibility (100 µg/mL) was measured using the Wayne method37. Any resistant strains 
underwent further DST for second-line agents performed using the indirect proportion method on 7H11 agar as 
previously described38–40. DNA was extracted and genotyped by 24-loci MIRU-VNTR using standard methods41. 
A ‘cluster’ in the study was defined as a group of isolates having an identical MIRU-VNTR pattern.
Whole-genome sequencing (WGS) and variant calling. Sixty-three isolates collected between 2009 
and 2012 were available for sequencing from the largest MIRU-VNTR cluster (n = 148) found in the study 
(Supplementary Table 3) based on the availability of culture for DNA extraction in 2013. DNA extraction, 
sequencing and read processing is described in the supplementary methods. Raw reads were processed and vari-
ants were called using a custom bioinformatics pipeline42 (supplementary methods).
Phylogenetic analysis. A multiple sequence alignment was generated as a concatenate of allelic states at 
all sites found to be variable using a custom script in Perl 5.10.142. We generated an alignment containing only 
substitutions and another with both substitutions and insertions and deletions (commonly referred to as ‘indels’). 
Variants in genes implicated in drug resistance43, transposases, and genes coding for proline-glutamate (PE) or 
proline-proline-glutamate (PPE)44 (commonly referred to as PE/PPEs) were excluded from phylogeny building 
by convention (e.g. due to high levels of recombination45), and also because drug resistance genes are under selec-
tive pressure and are expected to bias tree structure. A maximum likelihood phylogenetic tree was built for both 
alignments using RAxML 8.2.1146 as implemented in the R package ips47 (supplementary methods). Estimation 
of divergence times and timing of drug resistance acquisition was performed using BEAST 1.8.448,49 using an 
uncorrelated lognormal relaxed clock that allows for tree branches to evolve at different rates. The prior on the 
mean clock rate was assumed to be 0.5 SNP per genome per year based on published data3. We calculated the 
range of dates based on a 95% highest posterior density interval (HPDI) which indicates the smallest interval that 
includes 95% of the posterior probability distribution50. Please see supplementary methods for further details of 
the phylogenetic analysis.
To determine the number of times DR arose within the group of isolates, we examined the maximum clade 
credibility tree (where bifurcations denote internode branches supported by a posterior probability >0.5). We 
then counted the minimum number of paraphyletic switches from a sensitive to a resistant phenotype for each 
drug supported by bifurcating/high-confidence nodes.
SNPs occurring within a high-transmission cluster were further evaluated against other TB lineages using 
a large TB WGS database containing 12,032 strains curated from the literature through NCBI and the Reseq 
TB initiative51 (Supplementary Data 1). To determine SNPs with phylogenetic convergence, mutations in the 
high-transmission cluster that were present in more than 5% of strains in at least two other main lineages (i.e. 
lineages 1, 2 and 3) in addition to lineage 4 were identified as likely being under positive selection. As some of the 
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hit SNPs occurred in repetitive regions, we confirmed their accuracy by remapping simulated reads from different 
reference genomes and using Pacific Biosciences (PacBio) long-read sequences (supplementary methods).
Other data analysis. Variation in PE/PPE regions and indels between closely related strains was confirmed 
via visualization and checked for false positives due to copy number variants (supplementary methods). To study 
host-related factors that may be associated with transmission, the propensity to propagate (PTP) method was 
used as previously described52.
Results
Patient and isolate characteristics. A large cluster of 148 isolates, collected from 147 patients, with iden-
tical MIRU-VNTR pattern was identified. The majority of the patients in this cluster were male, HIV-negative and 
had multidrug resistant (MDR) TB (Table 1). About one-half were smear-positive (51.4%) and one-third used 
alcohol (35.8%) or other intoxicating substances (27.9%). From this cluster, 63 isolates were available for sequenc-
ing (supplementary methods). Two patients had isolates that did not meet our sequencing quality criteria and 
were subsequently excluded. Of those patients with high quality sequence data (n = 61) a higher majority were 
male with MDR-TB but were otherwise comparable to the superset of 148 (Table 1). Sequencing data revealed 
that 58 isolates belonged to the Latin America-Mediterranean LAM-4.3.3 sublineage, and three isolates were 
more distant and belonged to the sublineages X -4.1.1, T-4.8, and LAM-4.3.2. In the LAM-4.3.3 group, we found 
Cluster* With WGS**
Age*** 32.06 (17–86) 34.8 (17–86)
Female 47 (31.9%) 17 (28.3%)
Positive sputum smear 76 (51.7%) 30 (50%)
Heavy drinker in previous year 53 (36.1%) 24 (40%)
Drug use 41 (28.1%)(Total n = 146)
20 (33.9%)
(Total n = 59)
HIV positive 3 (2.2%)(Total n = 139)
3 (5.4%)
(Total n = 56)
Resistance Pattern# (N = 148) N (%) N (%)
Susceptible 26 (17.6) 9 (14.8)
  Isoniazid Resistant 18 (12.2) 13 (21.3)
  Multi-drug Resistant 56 (37.8) 31 (50.8)
  Other 36 (24.3) 8 (13.1)
  Not available 12 (8.1) 0 (0)
Table 1. Patient characteristics. None of the variables were significantly different between the patient with and 
without sequencing data using a t-test or a Chi-squared test. *N = 147 unless specified (including one patient 
with two isolates). **N = 60 unless specified (including one patient with two isolates). ***Mean and range. 
#Resistance pattern for three of the sequenced strains was inferred based on mutations.
Figure 1. Geographic location of strains with resistance pattern. (A) All 148 strains with identical MIRU-
VNTR patterns, (B) 61 strains that were sequenced. Maps generated using the plot() function as implemented 
in R package OutbreakTools70. MDR: multidrug-resistant (resistant to both isoniazid and rifampin).
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371 SNPs and 81 indels in total. Of these, 24 substitutions and one indel occurred in DR conferring regions, and 
42 substitutions and 23 indels in PE/PPE genes. With the exclusion of DR conferring regions, the average pairwise 
SNP difference between isolates was 21.69 (range: 0–84) and 22.7 (range: 1–100), excluding and including the PE/
PPE regions, respectively.
The geographic distribution of strains based on household coordinates, colored by resistance pattern is shown 
in Fig. 1. Comparison between genetic and geographic distance did not support that the cluster spread in a single 
geographic direction, even when three most distant strains were excluded (P = 0.2, Supplementary Fig. 1).
The SNP-based phylogenetic tree (Fig. 2, Supplementary Fig. 2) demonstrated that the most genetically homo-
geneous group consisted of 57 isolates. These formed two main clades, where the first contained isolates that were 
pan-susceptible or streptomycin mono-resistant, and the second consisted of INH mono-resistant or MDR iso-
lates. Using a prior on the mean clock rate of 0.5 SNP per genome per year3 (supplementary methods), the origin 
of the 61 isolates was estimated around the middle of the 14th century (1336 CE; 95%HPD 855–1680). The LAM-
4.3 cluster of 58 isolates diverged ca. 1923 (95%HPD 1856–1967) and innermost cluster of 57 isolates diverged ca. 
1968 (95%HPD 1945–1985).
Figure 2. Bayesian maximum clade credibility phylogenetic tree created via BEAST (using single nucleotide 
polymorphisms) of 61 strains with nodes in increasing order of age. Numbers at nodes are posterior means of 
node ages (years ago). Node ages <15 years are not shown for clarity. Bars represent 95%HPD interval for node 
age. Color of tip represents drug susceptibility - Green: pan-susceptible, Dark Red: Resistant only to Isoniazid or 
Rifampicin, Dark Green: Resistant to a drug other than Isoniazid or Rifampicin, Red: multi-drug resistant.
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Epidemiological vs. genotypic data. We compared the use of genetic and epidemiological data for 
transmission inference. PE/PPE region differences and indels between closely related pairs were visualized in 
Integrated Genome Viewer and confirmed to be high confidence (supplementary methods). Sequencing data 
was available for three of seven household contact pairs in the cluster of 147 patients. Only one household link 
(index/parent M23 – contact/child M12) was consistent with a recent transmission event on the tree and by 
genetic distance (SNP difference = 1). When high-confidence PE/PPE regions were included, the genetic dis-
tance between this pair increased to 3 variants. With the further addition of high confidence indels the pairwise 
distance increased to 4, in the predicted 5 year interval (Supplementary Data 2). No variation was observed in 
this pair in DR-related loci. The other two isolate pairs from household contacts (index/parent M02 – contact/
child M01, index/child M45 – contact/parent M58) were 17 and 421 SNPs apart, respectively. Isolates M01 and 
M02 were genetically closer to other isolates on the tree (M01-M28 6 SNPs apart and M02-M42-M11-M37 all 
within 4 SNPs of each other). A pair of isolates collected two months apart from a host who had not been on treat-
ment (MDR strains M06 and M10) was found to have no SNP differences outside of PE/PPE regions. In PE/PPE 
regions, we found 5 high-quality SNPs; similarly, 2 indels were observed in other regions.
Looking at genetic evidence alone for recent transmission using a distance cutoff of ≤5 SNPs (excluding DR 
and PE/PPE regions)3, 139 links among 38 patients were identified (Fig. 3). Other than one pair (index/parent 
M23 and contact/child M12), none of these belonged to the same household. With the addition of high confi-
dence indels and PE/PPE SNPs we used a cutoff of ≤12 variants: 5 SNPs plus 7 PE/PPE and indel variants based 
on the two serial isolates available from the same patient described above. Using this added variation and the cut-
off of ≤12, there were 104 links among 38 patients, i.e. 25% fewer links than when these variants were excluded. 
Phylogenetic trees built by including indel variation also had notable differences within the cluster of 57 isolates 
(Supplementary Fig. 3).
Of the 375 isolates sequenced from a TB outbreak in London13, 325 (86.67%) met our quality criteria and 
were further examined. Using a genetic distance cut-off of ≤5 SNPs (excluding DR and PE/PPE regions), 309 of 
these isolates diversified into one large interconnected cluster consisting of 31,776 links. Among 38 serial isolates 
that were collected from 19 patients from that outbreak, the largest difference between a pair with the inclusion 
of indels and PE/PPE regions was also found to be 7 SNPs. When applying this as the threshold for identifying 
a genetic link, the interconnected cluster was reduced to 294 strains with 28,230 links, i.e. 11% fewer links than 
when PE/PPE variants and indels were excluded.
Figure 3. Inferred transmission network based on genomic distance. Shown is a network graph depicting 
strains that were less than or equal to 5 single nucleotide polymorphisms (SNPs) apart (with the exclusion of 
PE/PPE regions and regions coding for drug resistance). Each vertex represents a strain or group of strains, 
edges are colored to denote number of SNP differences between the connected vertices. IG = Identical Group 
– consists of strains that had zero SNP difference, IG1 = M09, M14, M01; IG2 = M06, M10; IG3 = M04, M07; 
IG4 = M18, M28. Legend shows number of different SNPs and corresponding color of the edges. Plot generated 
using R package igraph.
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Host factors. We measured host infectiousness in the cluster using the ‘propensity to propagate’ (PTP) 
method52 and identified five patients as having the highest possible score (PTP > 4). This was related to patients 
being younger (20–29 years old) males with smear positive PTB and a history of substance use (Supplementary 
Fig. 4). Three of these were identified to be within the network of patients with genetically close MDR isolates 
(Fig. 3). The mean cluster PTP was also high at 1.699.
Drug resistance. First and second-line drug resistance was acquired several times within the core cluster of 
57 isolates (Table 2, Supplementary Fig. 5, and Supplementary Table 1).
First line drugs. Isoniazid (INH) resistance was acquired at least twice, and in both times with a katG S315T 
mutation, ca. 1968 (95%HPD: 1945–1985) and ca. 1972 (95%HPD 1952–1985). Rifampicin resistance (RR) was 
acquired within the large INH-resistant clade at least twice ca. 1980 (95%HPD: 1964–1990, rpoB D435V) and 
ca. 1986 (95%HPD: 1973–1996, most frequent variant rpoB S450L). Pyrazinamide (PZA) resistance followed 
RR and was acquired at least 4 times, the most frequent mutation was pncA Q10R acquired ca. 1980 (95%HPD: 
1964–1990), the most recent PZA resistance acquisition event was predicted to be within the last year of isolation 
(95%HPD: 2006–2012). Ethambutol resistance was acquired at least twice within the MDR clade and contempo-
raneous with RR acquisition in both cases. The mutation Y319S was the most common embB mutation observed.
Second line drugs. Of the 25 strains tested for ciprofloxacin, one MDR isolate (M43) acquired resistance ca. 1996 
(95%HPD: 1979–2009). Similarly, only one (M30, which was also resistant to capreomycin) of the 41 isolates 
tested for kanamycin acquired resistance ca. 2009 (95%HPD: 2006–2012). We were not able to identify any muta-
tions in gyr or rrs to explain resistance to these two drugs. For capreomycin, seven of forty tested isolates were 
resistant and carried the tlyA G232D mutation estimated to have been acquired ca. 2005 (95%HPD: 2001–2008).
Resistance and Bacterial Fitness. As there were several isolates measured to be resistant by the 
culture-based method that did not harbor any known resistance mutations, e.g. for EMB and PZA, we attempted 
a phylogeny-based genome wide association within the group of 61 isolates to identify new mutations associated 
with resistance (Supplementary Table 2). In addition to identifying the known mutations that confer resistance to 
isoniazid and rifampicin, we found an association between EMB resistance and a mutation (3778221AG) in the 
intergenic region between spoU and PE-PGRS51 genes (20 bp from spoU end and 347 bp before PE-PGRS51 start), 
corresponding to the acquisition of EMB resistance ca. 1980 (95%HPD: 1964-1990) shown in Supplementary Fig. 5.
We identified 175 mutations that were unique to the core cluster of 57 isolates and were absent from the four 
more distantly related isolates. Hypothesizing that a subset of these mutations may have contributed to transmis-
sibility of this cluster, we measured which are under positive selection by looking at 12,032 other MTB isolates. 
Five mutations met our criteria for positive selection i.e. were found to have a frequency of >5% in at least three 
other TB lineages (lineage 1, 2, 3, and non-LAM-4) (Fig. 4). Of the five, two occurred in genes with known func-
tion, esxV which is an ESAT-6 like secreted protein and cobD, a cobalamin biosynthesis protein. As three of the 
five genes are known to contain repetitive regions, the accuracy of the convergent mutation calls was verified by 
simulating and remapping Illumina reads carrying the variant, and using PacBio long read sequences that was 
available for one strain (supplementary methods).
Discussion
In this detailed analysis of a MIRU-VNTR cluster with variable degrees of drug resistance from a high prevalence 
setting, we show that traditional genotyping methods have a significantly lower resolution in identifying trans-
mission clusters as compared to WGS, particularly when variation in PE/PPE regions, indels are incorporated 
into the analysis. Additionally, we found complex evolutionary patterns within an otherwise identical MIRU 
cluster and identified the interplay of host and epidemiological factors contributing to transmission potential of 
a cluster.
The higher resolution gained by WGS is consistent with prior reports2,3,53–55, but the maximum genetic dis-
tance we find between the clustered isolates is larger than previously seen and we further estimate the group of 
LAM-4.3.3 sequenced isolates to have been circulating for over 8 decades in our study community. Previous 
studies performing WGS of MIRU-VNTR clusters in low prevalence settings have noted shorter genetic distance 
between isolates2,3,13, and in one case the distances were insufficient to reliably and consistently inform contact 
tracing interventions13. It is possible, that certain features of our selected cluster have led to the observation of 
Antibiotic
Minimum DR 
acquisition instances
Timing of DR acquisition (year, 
imputed based on posterior mean)
Isoniazid 2 1968, 1972
Rifampicin 2 1980, 1986
Pyrazinamide 5 1980, 1986, 1990, 2007, 2011
Ethambutol 3 1980, 1986, 1996
Ciprofloxacin 1 1996
Kanamycin 1 2009
Capreomycin 1 2003
Table 2. Drug resistance acquisition in MTB strains based on phenotype.
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such high levels of diversity. First, our cluster spans the spectrum of pan-susceptible to resistant against seven 
drugs. Second, epidemiological links were known for only three pairs of patients in the cluster. Third, our isolates 
all belong to lineage 4, a lineage that has been noted to be the most phenotypically and genotypically diverse of 
the TB lineages56. However, the proportion of diversity that could be linked directly to drug resistance was low. A 
parsimonious explanation of the high degree of observed genomic diversity is that the rate of MIRU-VNTR pat-
tern evolution is on average slow and on the order of decades. Despite this, MIRU-VNTR likely offers sufficient 
resolution in low prevalence settings as most TB cases there tend to be imported2,3.
The genes in the PE and PPE families constitute about 10% of the TB genome and have been grouped together 
based on the proline-glutamate (PE) and proline-proline-glutamate (PPE) signature motifs but members of this 
family are scattered throughout the genome and have diverse functions57,58. Because they carry a high GC con-
tent and contain repetitive areas they have been typically excluded from analysis of sequencing data59. However, 
recent advances in sequencing technology allow for longer read lengths and increased throughput, which when 
combined with more accurate bioinformatics pipelines, makes it possible to call variants in a proportion of these 
genes with high confidence. We identified several high quality indels and variation in the PE/PPE regions in our 
dataset. The commonly used cutoff of ≤5 SNPs to infer transmission does not take into account the different evo-
lutionary rate of these regions that may be driven by intra-genomic recombination or other mechanisms. In our 
study, when identifying closely related strains with the inclusion of high confidence PE/PPE regions, the number 
of possible links between strains decreased. An accepted standard that accounts for variation in these regions 
would allow for improved resolution of transmission events. Although, comparison of ancestral relationships in 
the phylogenetic trees with and without the inclusion of indels did not show significant differences, there were 
notable differences within the closely related cluster, highlighting that similarity measures that rely on SNPs alone 
could be misleading. Inclusion of indels and PE/PPE regions in the estimation of divergence dates is limited by 
our current lack of knowledge regarding their evolutionary rates or clock-like behavior. Prior studies support that 
at least a proportion of them accumulate variation in a manner consistent with lineage44 and coupled with our 
observation that these regions account for an appreciable proportion of variation seen between closely related 
isolates, including PE/PPE variants is likely to inform transmission inference.
We identified many genomic links using the SNP distance threshold of ≤5 criterion3 that were not discovered 
within household contact investigation, providing evidence that household contact investigation is not sufficient 
to identify and treat secondary TB cases as transmission can occur anywhere in the community60,61. Additionally, 
2 of 3 case pairs that belonged to the same household were found to have large genetic distances making it more 
likely that transmission occurred outside the household. Although the dataset used was relatively small, these 
findings add to the current limited literature on the topic60,62,63. Overall our study highlights the utility of WGS 
in resolving transmission links particularly in high burden settings where several transmission chains may 
occur simultaneously. WGS of a well characterized cluster through MIRU-VNTR led to identification of several 
sub-clusters with further granularity achieved from addition of variants in regions that are routinely excluded 
from these analyses. With decreasing cost of WGS, sequencing data could be integrated with epidemiological 
investigation in lieu of traditional fingerprinting methods to identify transmission clusters and for reconstruction 
of contact networks, particularly given the increasing emphasis on active case finding for TB elimination17.
Our phylogenetic dating procedures support the conclusion that the acquisition of MDR is not recent in Lima, 
and that MDR cases, given the observed phylogenetic structure, are mostly related to transmission. This finding 
is consistent with other studies carried out in other countries, e.g. South Africa18. Within the MDR subcluster, 
ethambutol and pyrazinamide resistance was acquired and transmitted. This finding is similar to that of a study 
Figure 4. Single nucleotide polymorphisms in high-transmission cluster of 57 strains showing phylogenetic 
convergence and their percent frequency among Mycobacterium tuberculosis lineages. LAM: Latin America-
Mediterranean.
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in Uganda64, where pyrazinamide resistance typically arose in MDR strains with several different causative muta-
tions. This highlights the importance of testing for pyrazinamide resistance in order to determine benefit of its 
use in MDR-TB treatment regimens65.
Phenotypic resistance could not be explained by genotype in a few isolates including in our study. To this 
effect, we undertook a GWAS procedure to identify drug resistant phenotype-genotype associations. We iden-
tified the intergenic SNP 3778221AG 30 bp downstream of the putative tRNA/rRNA methylase gene spoU to be 
significantly associated with ethambutol resistance. Although a causative mechanism for how this variant mod-
ulates EMB susceptibility or fitness is not clear, this finding is supported further by a recent large genome-wide 
association study of 1452 MTB isolates66.
The cluster under study was the largest such cluster observed in the Lima household transmission study. Its 
transmission success was likely due to both bacterial and host factors. We quantified the host predilection to 
transmit TB with the PTP measure and found the cluster to have a higher score than the median PTP measure 
reported by a study in Netherlands52. Our study had five patients with a particularly high PTP above the highest 
reported value of 3·952, potentially contributing to transmission in the population we studied. A few prior studies 
have characterized bacterial genetic factors that contributed to increased transmissibility24,67,68. We add to this lit-
erature by identifying five cluster defining SNPs to be under positive selection in a large TB genomic dataset. One 
of these SNPs (esxV S23L) is a member of the ESAT-6 family of secreted proteins, some of which have been shown 
to be involved in host-pathogen interactions and may thus have contributed to increased transmissibility68,69.
Our study had several limitations. Contact tracing was done within household contacts and hence epidemio-
logical links in the community were possibly missed. Sequencing a subset of isolates from the cluster may have led 
to missed links along the transmission chain. It may also have led to an underestimation of the diversity. However, 
the sampled subset demonstrated a substantial amount of diversity, more than would be expected within a clus-
ter with identical MIRU pattern2,3. We also cannot exclude that the 2 outer most isolates were mis-assigned the 
reported MIRU pattern and because of this we focused on the isolates confirmed to be of the same lineage by in 
silico spoligotyping and the WGS SNP barcode. Finally, it is important to note that our dating estimates are heav-
ily reliant on the molecular clock rate that has been previously reported in the literature.
In summary, our findings add to the evidence challenging the traditional interpretation of a MIRU-VNTR 
cluster as indicating recent transmission and suggest that the benefits of WGS over MIRU-VNTR may be even 
more prominent in high prevalence settings when TB transmission has been ongoing without interruption, espe-
cially when high confidence PE/PPE and indel genetic variants are included. WGS can also provide insights into 
biology of MTB to improve our understanding of DR, transmission and host-pathogen interaction.
Data Availability
Mycobacterium tuberculosis genome data were deposited in the NCBI BioProject database (ID: PRJ-
NA343736 and PRJNA526078). Individual accession numbers for genomes analyzed in this study are given in 
Supplementary Data 3.
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